Chemotherapy-induced modifications to gastrointestinal microflora: evidence and implications of change.
about
Influences of diet and the gut microbiome on epigenetic modulation in cancer and other diseasesChemotherapy-Induced Constipation and Diarrhea: Pathophysiology, Current and Emerging TreatmentsThe role of intestinal microbiota in development of irinotecan toxicity and in toxicity reduction through dietary fibres in ratsUnderstanding and managing toxicities of vascular endothelial growth factor (VEGF) inhibitorsProbiotics for prevention of radiation-induced diarrhea: A meta-analysis of randomized controlled trialsGut microbiome and anticancer immune response: really hot Sh*t!Vitamin D3 enhances the tumouricidal effects of 5-Fluorouracil through multipathway mechanisms in azoxymethane rat model of colon cancerIrinotecan (CPT-11) chemotherapy alters intestinal microbiota in tumour bearing rats.Irinotecan-induced mucositis: the interactions and potential role of GLP-2 analogues.Serum-derived bovine immunoglobulin/protein isolate in the alleviation of chemotherapy-induced mucositis.Influence of genetic polymorphisms in the folate pathway on toxicity after high-dose methotrexate treatment in pediatric osteosarcomaThymoquinone subdues tumor growth and potentiates the chemopreventive effect of 5-fluorouracil on the early stages of colorectal carcinogenesis in rats.Mucositis in malignant hematology.Evidence supporting the use of probiotics for the prevention and treatment of chemotherapy-induced intestinal mucositis.Interaction between host cells and microbes in chemotherapy-induced mucositis.Emerging evidence on the pathobiology of mucositis.Metabolic syndrome in pediatric cancer survivors: a mechanistic review.Gastrointestinal mucositis: the role of MMP-tight junction interactions in tissue injury.The role of oral flora in the development of chemotherapy-induced oral mucositis.Prebiotics: A Potential Treatment Strategy for the Chemotherapy-damaged Gut?Genistein and enterolactone in relation to Ki-67 expression and HER2 status in postmenopausal breast cancer patients.Risk factors and impact of Clostridium difficile recurrence on haematology patients.Risk factors associated with Clostridium difficile infection in adult oncology patients.Human intestinal microbiota gene risk factors for antibiotic-associated diarrhea: perspectives for prevention. Risk factors for antibiotic-associated diarrhea.Risk factors for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.Alteration of Gut Microbiota and Inflammatory Cytokine/Chemokine Profiles in 5-Fluorouracil Induced Intestinal Mucositis.Cell adhesion molecules are altered during irinotecan-induced mucositis: a qualitative histopathological study.Irinotecan-induced alterations in intestinal cell kinetics and extracellular matrix component expression in the Dark Agouti rat.Extensive impact of non-antibiotic drugs on human gut bacteria.[Side effect management of tyrosine kinase inhibitors in urology : Gastrointestinal side effects].Lactobacillus casei Variety rhamnosus Probiotic Preventively Attenuates 5-Fluorouracil/Oxaliplatin-Induced Intestinal Injury in a Syngeneic Colorectal Cancer Model.Bacterial Translocation Is Reduced by a Specific Nutritional Combination in Mice with Chemotherapy-Induced Neutropenia
P2860
Q26781968-523F7B3F-5F24-4A85-818D-0C79E2D439DFQ28079705-D3AE2C8A-2BFD-4A8B-8AE7-B47A5F3C1286Q28538671-A20A399E-6943-4709-992D-F2F654E9BDCDQ33698419-2A70A3E7-3701-4DEF-9FDC-266A0F41895BQ33757954-21DA5872-DB38-48C8-B2F0-7AD588B58EBCQ34924272-F9DF0DC0-44E1-400E-8A11-1C45EE032521Q35885755-6EB6F8F4-8CBE-4EB1-8D49-F4970A142B09Q36119996-921B9BF8-68F5-4D7E-95DE-9EDF30E63E21Q36171894-BD7BF7B9-C7E3-40D6-97BD-0E3430702E5AQ36346001-9F6C78C0-6A53-4666-92F6-7E80E660C495Q36789432-1C511720-F08A-4F38-BAD4-8912325C122EQ37098697-F820AD2C-5453-42C0-AE27-6402409682A9Q37810071-6A12B0FF-3727-4A1B-BB7A-01B3833E25FDQ37851431-8FB98EB4-D399-4497-93FD-D920944F961FQ38102867-04B6E4F9-BC09-4412-961B-08B7D9AA4CE5Q38120647-3391919F-9064-4630-BCD9-996FCE107060Q38126459-9AFD65BF-E312-43F1-98CF-630666083B4FQ38178513-6FC310C2-ACCB-4DAD-BD88-838FF82D6A93Q38185099-B770FC78-99DD-4AE0-8616-071D7120FF5BQ38243820-F3720818-0D9A-4D5F-A54C-7776D1F9D222Q38666974-A75ACE6C-68AB-453D-8D4C-2D0E8C1F151DQ40337382-5AC21F32-DA4A-4C03-AB86-56D87ABE7220Q41655888-AE8FBA4A-53F7-4162-AED4-23B68C7F50CDQ42136589-4131612F-BB87-4C29-8050-9040EFE8A80BQ44347574-CEF7D9A5-D64E-4E84-8F91-2E99900D56B6Q46734564-6BC7B090-B8CA-420E-810A-12ADE45A8491Q50228432-2DD76470-ADEA-47D8-A3EF-1D7E7EF90EE3Q50540999-2B4E66EE-C307-461E-AF56-5F4F609D20A5Q52647893-CC4C8B0D-2A31-4433-B80E-1401E3807C6CQ54196218-C83FABA4-5308-4D7B-BAD5-4A18B74F88C3Q55432763-DD335EEB-C8F4-48CF-8FF0-CE0F5C1ECEA3Q57984333-CA922AEC-2B58-40D4-870C-9620E8C9AEB3
P2860
Chemotherapy-induced modifications to gastrointestinal microflora: evidence and implications of change.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chemotherapy-induced modificat ...... ce and implications of change.
@en
Chemotherapy-induced modificat ...... ce and implications of change.
@nl
type
label
Chemotherapy-induced modificat ...... ce and implications of change.
@en
Chemotherapy-induced modificat ...... ce and implications of change.
@nl
prefLabel
Chemotherapy-induced modificat ...... ce and implications of change.
@en
Chemotherapy-induced modificat ...... ce and implications of change.
@nl
P50
P1476
Chemotherapy-induced modificat ...... nce and implications of change
@en
P2093
Dorothy M K Keefe
P356
10.2174/138920009787048419
P407
P577
2009-01-01T00:00:00Z